The ARF5 Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population derived from the HT29 human colorectal adenocarcinoma epithelial cell line, engineered to disrupt ARF5 gene function. This loss-of-function model enables detailed investigation of ARF5-dependent cellular processes without implying monoclonality or complete gene ablation, offering a heterogeneous population that reflects the diversity of editing outcomes and serves as a robust tool for studying ARF5 biology in a relevant intestinal epithelial context.
The HT29 cell line, originally isolated from a primary colon adenocarcinoma of a 44-year-old female, is extensively utilized in colorectal cancer research. These epithelial cells can differentiate under appropriate conditions, exhibiting characteristics of intestinal epithelium, and are thus highly suitable for investigating mechanisms of cell polarity, adhesion, and cancer progression. Their widespread use underscores the physiological relevance of this host background for evaluating gene function in colorectal adenocarcinoma.
ARF5 encodes a small GTPase that cycles between inactive GDP-bound and active GTP-bound states, recruiting coat protein complex I (COPI) to Golgi membranes upon activation by guanine nucleotide exchange factors such as GBF1 and BIG1/2. This process mediates retrograde Golgi-to-endoplasmic reticulum and intra-Golgi vesicular transport, while downstream effectors including phospholipase D and clathrin adaptors execute cargo sorting functions. ARF5 activity is tightly regulated by GTPase-activating proteins like ARFGAP1, and its proper function is essential for Golgi architecture and membrane trafficking, directly influencing the surface expression of adhesion molecules and growth factor receptors.
In the context of HT29 colorectal adenocarcinoma, disruption of ARF5 is anticipated to impair COPI-dependent trafficking, leading to defects in Golgi organization and altered recycling of adhesion molecules, integrins, and the EGF receptor. These perturbations can compromise epithelial cell polarity, migratory behavior, and signaling pathways that drive tumor progression and metastasis. Consequently, this knockout model provides a valuable platform for dissecting the contributions of membrane trafficking to the malignant phenotype of colorectal cancer cells.
Typical applications encompass immunofluorescence-based assessment of Golgi morphology, western blotting for COPI subunits to evaluate coat protein distribution, and flow cytometric analysis of surface receptor expression. Functional assays such as wound healing and migration studies reveal ARF5-dependent changes in cell motility, while co-immunoprecipitation facilitates mapping of ARF5 interactors with COPI and GGA adaptors. RT-qPCR can monitor transcriptional responses downstream of trafficking defects, and temperature-sensitive reporters enable kinetic analysis of Golgi transport. For additional details or to discuss custom applications, please contact Ascent Research.
